SIMILAR PATTERNS OF AMINO ACIDS FOR 4DZ2_B_FK5B200_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1eom | ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F3 (Elizabethkingiameningoseptica) |
PF00704(Glyco_hydro_18) | 5 | ASP A 34VAL A 284ILE A 271TYR A 274ILE A 29 | None | 1.31A | 4dz2A-1eomA:undetectable4dz2B-1eomA:undetectable | 4dz2A-1eomA:16.324dz2B-1eomA:16.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fd9 | PROTEIN (MACROPHAGEINFECTIVITYPOTENTIATOR PROTEIN) (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 6 | PHE A 153ILE A 159TRP A 162TYR A 185ILE A 194PHE A 202 | None | 1.12A | 4dz2A-1fd9A:18.24dz2B-1fd9A:18.2 | 4dz2A-1fd9A:21.804dz2B-1fd9A:21.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fd9 | PROTEIN (MACROPHAGEINFECTIVITYPOTENTIATOR PROTEIN) (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 8 | TYR A 131ASP A 142VAL A 158ILE A 159TRP A 162TYR A 185ILE A 194PHE A 202 | None | 0.57A | 4dz2A-1fd9A:18.24dz2B-1fd9A:18.2 | 4dz2A-1fd9A:21.804dz2B-1fd9A:21.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fkk | FK506 BINDINGPROTEIN (Bos taurus) |
PF00254(FKBP_C) | 10 | TYR A 26ASP A 37ARG A 42PHE A 46VAL A 55ILE A 56TRP A 59TYR A 82ILE A 91PHE A 99 | None | 0.71A | 4dz2A-1fkkA:18.84dz2B-1fkkA:18.8 | 4dz2A-1fkkA:54.874dz2B-1fkkA:54.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1hxj | BETA-GLUCOSIDASE (Zea mays) |
PF00232(Glyco_hydro_1) | 5 | TYR A 163PHE A 151VAL A 140TRP A 96PHE A 166 | None | 1.35A | 4dz2A-1hxjA:undetectable4dz2B-1hxjA:undetectable | 4dz2A-1hxjA:12.744dz2B-1hxjA:12.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 7 | ARG A 108PHE A 114ILE A 120TRP A 123TYR A 146ILE A 155PHE A 163 | None | 1.02A | 4dz2A-1jvwA:16.74dz2B-1jvwA:16.7 | 4dz2A-1jvwA:32.544dz2B-1jvwA:32.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 8 | TYR A 92ARG A 108VAL A 119ILE A 120TRP A 123TYR A 146ILE A 155PHE A 163 | None | 0.57A | 4dz2A-1jvwA:16.74dz2B-1jvwA:16.7 | 4dz2A-1jvwA:32.544dz2B-1jvwA:32.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 8 | TYR A 92ASP A 103ARG A 108ILE A 120TRP A 123TYR A 146ILE A 155PHE A 163 | None | 0.70A | 4dz2A-1jvwA:16.74dz2B-1jvwA:16.7 | 4dz2A-1jvwA:32.544dz2B-1jvwA:32.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kt1 | FK506-BINDINGPROTEIN FKBP51 (Saimiriboliviensis) |
PF00254(FKBP_C)PF00515(TPR_1)PF13181(TPR_8) | 7 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113PHE A 130 | None | 0.80A | 4dz2A-1kt1A:16.04dz2B-1kt1A:16.0 | 4dz2A-1kt1A:13.484dz2B-1kt1A:13.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1n1a | FKBP52 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | None | 0.55A | 4dz2A-1n1aA:18.84dz2B-1n1aA:18.9 | 4dz2A-1n1aA:47.454dz2B-1n1aA:47.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1pbk | FKBP25 (Homo sapiens) |
PF00254(FKBP_C) | 6 | PHE A 164ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | NoneRAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 1.36A | 4dz2A-1pbkA:17.94dz2B-1pbkA:17.9 | 4dz2A-1pbkA:41.324dz2B-1pbkA:41.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1pbk | FKBP25 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.32A | 4dz2A-1pbkA:17.94dz2B-1pbkA:17.9 | 4dz2A-1pbkA:41.324dz2B-1pbkA:41.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1q6h | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA (Escherichiacoli) |
PF00254(FKBP_C)PF01346(FKBP_N) | 6 | PHE A 168ILE A 174TRP A 177TYR A 200ILE A 208PHE A 216 | None | 1.26A | 4dz2A-1q6hA:18.44dz2B-1q6hA:18.4 | 4dz2A-1q6hA:30.964dz2B-1q6hA:30.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1q6h | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA (Escherichiacoli) |
PF00254(FKBP_C)PF01346(FKBP_N) | 9 | TYR A 146ASP A 157ARG A 162VAL A 173ILE A 174TRP A 177TYR A 200ILE A 208PHE A 216 | None | 0.69A | 4dz2A-1q6hA:18.44dz2B-1q6hA:18.4 | 4dz2A-1q6hA:30.964dz2B-1q6hA:30.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1r9h | FK506 BINDINGPROTEIN FAMILY (Caenorhabditiselegans) |
PF00254(FKBP_C) | 10 | TYR A 40ASP A 51ARG A 56PHE A 60VAL A 69ILE A 70TRP A 73TYR A 96ILE A 105PHE A 113 | None | 0.66A | 4dz2A-1r9hA:20.04dz2B-1r9hA:20.2 | 4dz2A-1r9hA:45.604dz2B-1r9hA:45.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rc7 | RIBONUCLEASE III (Aquifexaeolicus) |
PF00035(dsrm)PF14622(Ribonucleas_3_3) | 5 | ASP A 138PHE A 109VAL A 47ILE A 51PHE A 79 | None | 1.36A | 4dz2A-1rc7A:undetectable4dz2B-1rc7A:undetectable | 4dz2A-1rc7A:16.594dz2B-1rc7A:16.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ry2 | ACETYL-COENZYME ASYNTHETASE 1 (Saccharomycescerevisiae) |
PF00501(AMP-binding)PF13193(AMP-binding_C)PF16177(ACAS_N) | 5 | PHE A 349VAL A 466ILE A 465TYR A 454ILE A 458 | None | 1.03A | 4dz2A-1ry2A:undetectable4dz2B-1ry2A:undetectable | 4dz2A-1ry2A:9.594dz2B-1ry2A:9.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1u79 | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASE3 (Arabidopsisthaliana) |
PF00254(FKBP_C) | 8 | TYR A 37ASP A 48VAL A 66ILE A 67TRP A 70TYR A 99ILE A 113PHE A 121 | None | 0.44A | 4dz2A-1u79A:20.54dz2B-1u79A:20.5 | 4dz2A-1u79A:42.194dz2B-1u79A:42.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xv2 | HYPOTHETICALPROTEIN, SIMILAR TOALPHA-ACETOLACTATEDECARBOXYLASE (Staphylococcusaureus) |
PF03306(AAL_decarboxy) | 5 | MET A 103PHE A 172VAL A 112ILE A 114PHE A 190 | None | 1.35A | 4dz2A-1xv2A:undetectable4dz2B-1xv2A:undetectable | 4dz2A-1xv2A:19.834dz2B-1xv2A:19.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1yat | FK506 BINDINGPROTEIN (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 10 | TYR A 26ASP A 37ARG A 42PHE A 46VAL A 55ILE A 56TRP A 59TYR A 82ILE A 91PHE A 99 | FK5 A 108 ( 4.0A)FK5 A 108 ( 3.3A)FK5 A 108 (-3.7A)FK5 A 108 ( 4.0A)FK5 A 108 ( 3.4A)FK5 A 108 ( 3.7A)FK5 A 108 ( 3.6A)FK5 A 108 ( 4.7A)NoneNone | 0.54A | 4dz2A-1yatA:21.04dz2B-1yatA:21.1 | 4dz2A-1yatA:50.884dz2B-1yatA:50.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2eb1 | ENDORIBONUCLEASEDICER (Homo sapiens) |
PF00636(Ribonuclease_3) | 5 | MET A 179TYR A 99PHE A 11ILE A 153ILE A 111 | None | 1.05A | 4dz2A-2eb1A:undetectable4dz2B-2eb1A:undetectable | 4dz2A-2eb1A:17.744dz2B-2eb1A:17.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2lpv | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Aedes aegypti) |
PF00254(FKBP_C) | 5 | TYR A 27PHE A 47ILE A 57TRP A 60ILE A 92 | None | 1.09A | 4dz2A-2lpvA:16.14dz2B-2lpvA:16.2 | 4dz2A-2lpvA:50.434dz2B-2lpvA:50.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2lpv | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Aedes aegypti) |
PF00254(FKBP_C) | 5 | TYR A 27VAL A 56ILE A 57TRP A 60ILE A 92 | None | 1.07A | 4dz2A-2lpvA:16.14dz2B-2lpvA:16.2 | 4dz2A-2lpvA:50.434dz2B-2lpvA:50.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2pbc | FK506-BINDINGPROTEIN 2 (Homo sapiens) |
PF00254(FKBP_C) | 6 | PHE A 78ILE A 86TRP A 89TYR A 112ILE A 121PHE A 129 | NonePEG A 201 (-3.8A)PEG A 201 (-3.7A)NoneNoneNone | 1.43A | 4dz2A-2pbcA:16.24dz2B-2pbcA:16.1 | 4dz2A-2pbcA:56.254dz2B-2pbcA:56.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2pbc | FK506-BINDINGPROTEIN 2 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 56ASP A 67PHE A 76VAL A 85ILE A 86TRP A 89TYR A 112ILE A 121PHE A 129 | PEG A 201 (-4.4A)NonePEG A 201 ( 3.9A)PEG A 201 (-3.6A)PEG A 201 (-3.8A)PEG A 201 (-3.7A)NoneNoneNone | 0.78A | 4dz2A-2pbcA:16.24dz2B-2pbcA:16.1 | 4dz2A-2pbcA:56.254dz2B-2pbcA:56.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 5 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.73A | 4dz2A-2vcdA:15.34dz2B-2vcdA:15.4 | 4dz2A-2vcdA:33.334dz2B-2vcdA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 5 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.74A | 4dz2A-2vcdA:15.34dz2B-2vcdA:15.4 | 4dz2A-2vcdA:33.334dz2B-2vcdA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 5 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.63A | 4dz2A-2vcdA:15.34dz2B-2vcdA:15.4 | 4dz2A-2vcdA:33.334dz2B-2vcdA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 5 | VAL A 82ILE A 83TRP A 86TYR A 109PHE A 126 | RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A)RAP A 138 ( 4.7A) | 0.92A | 4dz2A-2vcdA:15.34dz2B-2vcdA:15.4 | 4dz2A-2vcdA:33.334dz2B-2vcdA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2vn1 | 70 KDAPEPTIDYLPROLYLISOMERASE (Plasmodiumfalciparum) |
PF00254(FKBP_C) | 10 | TYR A 44ASP A 56ARG A 61PHE A 65VAL A 74ILE A 75TRP A 78TYR A 101ILE A 110PHE A 118 | FK5 A 501 (-4.1A)FK5 A 501 (-3.4A)FK5 A 501 (-3.9A)FK5 A 501 (-4.1A)FK5 A 501 (-3.5A)FK5 A 501 (-4.3A)FK5 A 501 (-3.3A)FK5 A 501 (-4.7A)NoneFK5 A 501 (-4.8A) | 0.55A | 4dz2A-2vn1A:20.24dz2B-2vn1A:20.3 | 4dz2A-2vn1A:40.944dz2B-2vn1A:40.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2y78 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 10 | TYR A 33ASP A 44ARG A 49PHE A 53VAL A 62ILE A 63TRP A 66TYR A 89ILE A 98PHE A 106 | None | 0.72A | 4dz2A-2y78A:23.44dz2B-2y78A:23.5 | 4dz2A-2y78A:85.504dz2B-2y78A:85.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3b7x | FK506-BINDINGPROTEIN 6 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 61ASP A 73TYR A 118ILE A 127PHE A 135 | None | 0.91A | 4dz2A-3b7xA:15.74dz2B-3b7xA:15.7 | 4dz2A-3b7xA:28.794dz2B-3b7xA:28.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bo6 | HYDROPHILIC PROTEIN,VIRA PROTEIN (Chromobacteriumviolaceum) |
PF03536(VRP3) | 5 | MET A 44TYR A 212ASP A 103ILE A 180ILE A 132 | None | 1.39A | 4dz2A-3bo6A:undetectable4dz2B-3bo6A:undetectable | 4dz2A-3bo6A:20.914dz2B-3bo6A:20.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3c4b | ENDORIBONUCLEASEDICER (Mus musculus) |
PF00636(Ribonuclease_3) | 5 | MET A1821TYR A1741PHE A1653ILE A1795ILE A1753 | None | 1.10A | 4dz2A-3c4bA:undetectable4dz2B-3c4bA:undetectable | 4dz2A-3c4bA:16.734dz2B-3c4bA:16.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3clo | TRANSCRIPTIONALREGULATOR (Bacteroidesthetaiotaomicron) |
PF00196(GerE) | 5 | ASP A 82PHE A 106VAL A 142TYR A 160ILE A 86 | None | 1.37A | 4dz2A-3cloA:undetectable4dz2B-3cloA:undetectable | 4dz2A-3cloA:19.834dz2B-3cloA:19.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h2t | BASEPLATE STRUCTURALPROTEIN GP6 (Escherichiavirus T4) |
no annotation | 5 | ARG A 586VAL A 541ILE A 540ILE A 606PHE A 515 | None | 1.17A | 4dz2A-3h2tA:undetectable4dz2B-3h2tA:undetectable | 4dz2A-3h2tA:18.464dz2B-3h2tA:18.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h2t | BASEPLATE STRUCTURALPROTEIN GP6 (Escherichiavirus T4) |
no annotation | 5 | TYR A 536ASP A 562ARG A 521TYR A 590ILE A 609 | None | 1.14A | 4dz2A-3h2tA:undetectable4dz2B-3h2tA:undetectable | 4dz2A-3h2tA:18.464dz2B-3h2tA:18.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3i9f | PUTATIVE TYPE 11METHYLTRANSFERASE (Sulfolobussolfataricus) |
PF08241(Methyltransf_11) | 5 | TYR A 147ASP A 126PHE A 151VAL A 122ILE A 123 | None | 1.34A | 4dz2A-3i9fA:undetectable4dz2B-3i9fA:undetectable | 4dz2A-3i9fA:21.694dz2B-3i9fA:21.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ibp | CHROMOSOME PARTITIONPROTEIN MUKB (Escherichiacoli) |
PF16330(MukB_hinge) | 5 | TYR A 690ASP A 746PHE A 778ILE A 737PHE A 744 | None | 1.41A | 4dz2A-3ibpA:undetectable4dz2B-3ibpA:undetectable | 4dz2A-3ibpA:16.214dz2B-3ibpA:16.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3j9d | OUTER CAPSID PROTEINVP2 (Bluetonguevirus) |
PF00898(Orbi_VP2) | 6 | ASP A 679ARG A 685VAL A 712ILE A 701TYR A 745ILE A 674 | None | 1.38A | 4dz2A-3j9dA:undetectable4dz2B-3j9dA:undetectable | 4dz2A-3j9dA:7.394dz2B-3j9dA:7.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3j9t | V-TYPE PROTON ATPASESUBUNIT E (Saccharomycescerevisiae) |
no annotation | 5 | TYR K 117ASP K 145ARG K 144ILE K 125ILE K 174 | None | 1.39A | 4dz2A-3j9tK:undetectable4dz2B-3j9tK:undetectable | 4dz2A-3j9tK:17.244dz2B-3j9tK:17.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o5d | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | None | 0.78A | 4dz2A-3o5dA:18.94dz2B-3o5dA:19.0 | 4dz2A-3o5dA:34.884dz2B-3o5dA:34.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o5e | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TYR A 113ILE A 122PHE A 130 | None | 0.73A | 4dz2A-3o5eA:19.04dz2B-3o5eA:19.2 | 4dz2A-3o5eA:41.844dz2B-3o5eA:41.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o5e | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | None | 0.76A | 4dz2A-3o5eA:19.04dz2B-3o5eA:19.2 | 4dz2A-3o5eA:41.844dz2B-3o5eA:41.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3pa7 | 70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE (Plasmodiumvivax) |
PF00254(FKBP_C) | 10 | TYR A 43ASP A 55ARG A 60PHE A 64VAL A 73ILE A 74TRP A 77TYR A 100ILE A 109PHE A 117 | None | 0.68A | 4dz2A-3pa7A:19.94dz2B-3pa7A:19.9 | 4dz2A-3pa7A:40.324dz2B-3pa7A:40.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qnk | PUTATIVE LIPOPROTEIN (Bacteroidesfragilis) |
PF07980(SusD_RagB)PF14322(SusD-like_3) | 5 | MET A 370TYR A 396VAL A 363ILE A 354ILE A 389 | None | 1.31A | 4dz2A-3qnkA:undetectable4dz2B-3qnkA:undetectable | 4dz2A-3qnkA:15.204dz2B-3qnkA:15.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3t6a | BREAST CANCERANTI-ESTROGENRESISTANCE PROTEIN 3 (Homo sapiens) |
PF00617(RasGEF) | 5 | MET A 641ARG A 562PHE A 768VAL A 551ILE A 777 | None | 1.39A | 4dz2A-3t6aA:undetectable4dz2B-3t6aA:undetectable | 4dz2A-3t6aA:14.334dz2B-3t6aA:14.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3um6 | BIFUNCTIONALDIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE (Plasmodiumfalciparum) |
PF00186(DHFR_1)PF00303(Thymidylat_synt) | 5 | TYR A 569VAL A 210ILE A 224TYR A 226ILE A 200 | None | 1.22A | 4dz2A-3um6A:undetectable4dz2B-3um6A:undetectable | 4dz2A-3um6A:10.604dz2B-3um6A:10.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b3i | FATTY ACIDBETA-OXIDATIONCOMPLEX ALPHA-CHAINFADB (Mycobacteriumtuberculosis) |
PF00378(ECH_1)PF00725(3HCDH)PF02737(3HCDH_N) | 5 | ASP A 491ARG A 316ILE A 461ILE A 496PHE A 407 | None | 1.36A | 4dz2A-4b3iA:undetectable4dz2B-4b3iA:undetectable | 4dz2A-4b3iA:11.224dz2B-4b3iA:11.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 7 | ASP A 324VAL A 341ILE A 342TRP A 345TYR A 368ILE A 376PHE A 384 | None | 0.77A | 4dz2A-4bf8A:18.54dz2B-4bf8A:18.5 | 4dz2A-4bf8A:41.534dz2B-4bf8A:41.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 7 | TYR A 313ASP A 324PHE A 332VAL A 341ILE A 342TRP A 345PHE A 384 | None | 0.89A | 4dz2A-4bf8A:18.54dz2B-4bf8A:18.5 | 4dz2A-4bf8A:41.534dz2B-4bf8A:41.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 7 | TYR A 313ASP A 324VAL A 341ILE A 342TRP A 345TYR A 368PHE A 384 | None | 0.76A | 4dz2A-4bf8A:18.54dz2B-4bf8A:18.5 | 4dz2A-4bf8A:41.534dz2B-4bf8A:41.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ckm | SAS-6 (Leishmaniamajor) |
PF16531(SAS-6_N) | 5 | TYR A 196PHE A 209VAL A 173ILE A 263PHE A 199 | None | 1.40A | 4dz2A-4ckmA:undetectable4dz2B-4ckmA:undetectable | 4dz2A-4ckmA:20.004dz2B-4ckmA:20.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dip | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP14 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 52TRP A 88TYR A 111ILE A 119PHE A 127 | None | 0.55A | 4dz2A-4dipA:17.54dz2B-4dipA:17.5 | 4dz2A-4dipA:41.184dz2B-4dipA:41.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dz3 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 10 | TYR A 33ASP A 44ARG A 49PHE A 53VAL A 62ILE A 63TRP A 66TYR A 89ILE A 98PHE A 106 | FK5 A 201 ( 3.9A)FK5 A 201 (-3.5A)FK5 A 201 ( 3.7A)FK5 A 201 (-4.1A)FK5 A 201 ( 3.6A)FK5 A 201 (-3.8A)FK5 A 201 (-3.4A)FK5 A 201 (-4.7A)NoneFK5 A 201 (-4.8A) | 0.51A | 4dz2A-4dz3A:25.04dz2B-4dz3A:25.0 | 4dz2A-4dz3A:98.234dz2B-4dz3A:98.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4h09 | HYPOTHETICAL LEUCINERICH REPEAT PROTEIN (Eubacteriumventriosum) |
PF13306(LRR_5) | 5 | PHE A 337VAL A 346ILE A 369ILE A 375PHE A 383 | None | 1.29A | 4dz2A-4h09A:undetectable4dz2B-4h09A:undetectable | 4dz2A-4h09A:17.574dz2B-4h09A:17.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4iqc | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B (Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 26ARG A 42PHE A 46VAL A 55ILE A 56TYR A 82PHE A 99 | None | 0.85A | 4dz2A-4iqcA:18.54dz2B-4iqcA:18.5 | 4dz2A-4iqcA:50.004dz2B-4iqcA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4iqc | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B (Homo sapiens) |
PF00254(FKBP_C) | 6 | TYR A 26ASP A 37ARG A 42ILE A 56TYR A 82PHE A 99 | None | 0.72A | 4dz2A-4iqcA:18.54dz2B-4iqcA:18.5 | 4dz2A-4iqcA:50.004dz2B-4iqcA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4iqc | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B (Homo sapiens) |
PF00254(FKBP_C) | 6 | TYR A 26ASP A 37ILE A 56TYR A 82ILE A 91PHE A 99 | None | 0.64A | 4dz2A-4iqcA:18.54dz2B-4iqcA:18.5 | 4dz2A-4iqcA:50.004dz2B-4iqcA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4iqc | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B (Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 26PHE A 46VAL A 55ILE A 56TYR A 82ILE A 91PHE A 99 | None | 0.70A | 4dz2A-4iqcA:18.54dz2B-4iqcA:18.5 | 4dz2A-4iqcA:50.004dz2B-4iqcA:50.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4iyk | UNCHARACTERIZEDPROTEIN (Bacteroidesuniformis) |
PF12866(DUF3823) | 5 | VAL A 111ILE A 30TYR A 76ILE A 53PHE A 103 | None | 1.38A | 4dz2A-4iykA:undetectable4dz2B-4iykA:undetectable | 4dz2A-4iykA:21.834dz2B-4iykA:21.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57ARG A 73VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.87A | 4dz2A-4lawA:19.14dz2B-4lawA:19.2 | 4dz2A-4lawA:30.734dz2B-4lawA:30.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneDMS A 304 (-4.3A) | 0.68A | 4dz2A-4lawA:19.14dz2B-4lawA:19.2 | 4dz2A-4lawA:30.734dz2B-4lawA:30.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.53A | 4dz2A-4lawA:19.14dz2B-4lawA:19.2 | 4dz2A-4lawA:30.734dz2B-4lawA:30.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4msp | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP14 (Homo sapiens) |
PF00254(FKBP_C)PF13499(EF-hand_7) | 5 | TYR A 33TRP A 69TYR A 92ILE A 100PHE A 108 | None | 0.52A | 4dz2A-4mspA:18.24dz2B-4mspA:18.2 | 4dz2A-4mspA:35.424dz2B-4mspA:35.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4nnr | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 56ASP A 67PHE A 76VAL A 85ILE A 86TRP A 89TYR A 112ILE A 121PHE A 129 | FK5 A 201 (-4.1A)FK5 A 201 (-3.4A)FK5 A 201 (-4.0A)FK5 A 201 (-3.4A)FK5 A 201 (-3.8A)FK5 A 201 (-3.5A)FK5 A 201 (-4.5A)NoneFK5 A 201 (-4.9A) | 0.23A | 4dz2A-4nnrA:16.34dz2B-4nnrA:16.4 | 4dz2A-4nnrA:44.784dz2B-4nnrA:44.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4odm | PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD (Thermusthermophilus) |
PF00254(FKBP_C) | 5 | TYR A 13ASP A 23ILE A 37TYR A 63PHE A 128 | None | 0.52A | 4dz2A-4odmA:11.54dz2B-4odmA:11.5 | 4dz2A-4odmA:22.154dz2B-4odmA:22.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4odr | PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A CHIMERA (Homo sapiens;Thermusthermophilus) |
PF00254(FKBP_C) | 6 | TYR A 13ASP A 23ILE A 37TYR A 63ILE A 72PHE A 80 | FK5 A 201 ( 3.6A)FK5 A 201 (-3.6A)FK5 A 201 (-3.9A)FK5 A 201 (-4.4A)NoneFK5 A 201 ( 4.8A) | 0.44A | 4dz2A-4odrA:13.24dz2B-4odrA:13.2 | 4dz2A-4odrA:25.714dz2B-4odrA:25.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4psw | HISTONEACETYLTRANSFERASETYPE B CATALYTICSUBUNIT (Saccharomycescerevisiae) |
PF00583(Acetyltransf_1)PF10394(Hat1_N) | 5 | VAL A 24ILE A 23TYR A 226ILE A 188PHE A 63 | None | 1.20A | 4dz2A-4pswA:undetectable4dz2B-4pswA:undetectable | 4dz2A-4pswA:16.884dz2B-4pswA:16.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0x | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 6 | PHE A 79ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | None | 1.45A | 4dz2A-4r0xA:19.84dz2B-4r0xA:19.8 | 4dz2A-4r0xA:45.834dz2B-4r0xA:45.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0x | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 57ASP A 68ARG A 73PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113PHE A 130 | None | 0.86A | 4dz2A-4r0xA:19.84dz2B-4r0xA:19.8 | 4dz2A-4r0xA:45.834dz2B-4r0xA:45.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0x | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | None | 0.72A | 4dz2A-4r0xA:19.84dz2B-4r0xA:19.8 | 4dz2A-4r0xA:45.834dz2B-4r0xA:45.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4txw | HYALURONOGLUCOSAMINIDASE (Clostridiumperfringens) |
PF00754(F5_F8_type_C) | 5 | TYR A 7VAL A 145ILE A 146TYR A 52ILE A 67 | None | 1.40A | 4dz2A-4txwA:undetectable4dz2B-4txwA:undetectable | 4dz2A-4txwA:22.494dz2B-4txwA:22.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4u0t | ADC-7 BETA-LACTAMASE (Acinetobacterbaumannii) |
PF00144(Beta-lactamase) | 5 | MET A 231PHE A 179VAL A 224ILE A 155PHE A 170 | None | 1.40A | 4dz2A-4u0tA:undetectable4dz2B-4u0tA:undetectable | 4dz2A-4u0tA:16.714dz2B-4u0tA:16.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z7l | CAS6B (Methanococcusmaripaludis) |
PF17262(DUF5328) | 5 | TYR A 31ILE A 63TYR A 10ILE A 94PHE A 27 | None | 1.29A | 4dz2A-4z7lA:undetectable4dz2B-4z7lA:undetectable | 4dz2A-4z7lA:18.834dz2B-4z7lA:18.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zmh | UNCHARACTERIZEDPROTEIN (Saccharophagusdegradans) |
PF15979(Glyco_hydro_115) | 5 | ASP A 944PHE A 845ILE A 840TYR A 459ILE A 883 | None | 1.10A | 4dz2A-4zmhA:undetectable4dz2B-4zmhA:undetectable | 4dz2A-4zmhA:8.634dz2B-4zmhA:8.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5b2o | CRISPR-ASSOCIATEDENDONUCLEASE CAS9 (Francisellatularensis) |
no annotation | 5 | PHE A1576VAL A1561ILE A1547TYR A1549ILE A1611 | None | 1.26A | 4dz2A-5b2oA:undetectable4dz2B-5b2oA:undetectable | 4dz2A-5b2oA:5.484dz2B-5b2oA:5.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b8i | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Coccidioidesimmitis) |
PF00254(FKBP_C) | 10 | TYR C 36ASP C 56ARG C 61PHE C 64VAL C 73ILE C 74TRP C 77TYR C 100ILE C 109PHE C 117 | FK5 C 201 (-4.1A)FK5 C 201 ( 3.8A)FK5 C 201 (-3.8A)FK5 C 201 (-3.8A)FK5 C 201 (-3.5A)FK5 C 201 (-3.8A)FK5 C 201 (-3.4A)FK5 C 201 (-4.5A)NoneFK5 C 201 (-4.7A) | 0.72A | 4dz2A-5b8iC:17.84dz2B-5b8iC:17.8 | 4dz2A-5b8iC:39.684dz2B-5b8iC:39.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i7p | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A,FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A (Escherichiacoli;Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 26ASP A 37ARG A 42PHE A 46VAL A 55ILE A 56TRP A 59TYR A 82PHE A 146 | None | 0.66A | 4dz2A-5i7pA:16.94dz2B-5i7pA:16.9 | 4dz2A-5i7pA:35.624dz2B-5i7pA:35.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i7q | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A,FKBP-TYPE 16KDA PEPTIDYL-PROLYLCIS-TRANSISOMERASE,PEPTIDYL-PROLYL CIS-TRANSISOMERASE FKBP1A (Escherichiacoli;Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 26ASP A 37ARG A 42PHE A 46VAL A 55ILE A 56TRP A 59TYR A 82PHE A 147 | None | 0.71A | 4dz2A-5i7qA:17.24dz2B-5i7qA:17.3 | 4dz2A-5i7qA:39.754dz2B-5i7qA:39.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i98 | FK506-BINDINGPROTEIN 1 (Candidaalbicans) |
PF00254(FKBP_C) | 9 | TYR A 30ARG A 46PHE A 50VAL A 59ILE A 60TRP A 63TYR A 97ILE A 106PHE A 114 | None | 0.76A | 4dz2A-5i98A:18.14dz2B-5i98A:18.1 | 4dz2A-5i98A:47.064dz2B-5i98A:47.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i98 | FK506-BINDINGPROTEIN 1 (Candidaalbicans) |
PF00254(FKBP_C) | 7 | TYR A 30ARG A 46PHE A 50VAL A 59ILE A 60TYR A 97ILE A 102 | None | 1.44A | 4dz2A-5i98A:18.14dz2B-5i98A:18.1 | 4dz2A-5i98A:47.064dz2B-5i98A:47.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i98 | FK506-BINDINGPROTEIN 1 (Candidaalbicans) |
PF00254(FKBP_C) | 9 | TYR A 30ASP A 41PHE A 50VAL A 59ILE A 60TRP A 63TYR A 97ILE A 106PHE A 114 | None | 0.49A | 4dz2A-5i98A:18.14dz2B-5i98A:18.1 | 4dz2A-5i98A:47.064dz2B-5i98A:47.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i98 | FK506-BINDINGPROTEIN 1 (Candidaalbicans) |
PF00254(FKBP_C) | 7 | TYR A 30ASP A 41PHE A 50VAL A 59ILE A 60TYR A 97ILE A 102 | None | 1.42A | 4dz2A-5i98A:18.14dz2B-5i98A:18.1 | 4dz2A-5i98A:47.064dz2B-5i98A:47.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5j6e | FK506-BINDINGPROTEIN 1A (Aspergillusfumigatus) |
PF00254(FKBP_C) | 10 | TYR A 27ASP A 38ARG A 43PHE A 47VAL A 56ILE A 57TRP A 60TYR A 83ILE A 92PHE A 100 | None | 0.71A | 4dz2A-5j6eA:19.14dz2B-5j6eA:19.2 | 4dz2A-5j6eA:52.634dz2B-5j6eA:52.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jcv | LMO2181 PROTEIN (Listeriamonocytogenes) |
PF04203(Sortase) | 5 | ASP A 125VAL A 75ILE A 89TYR A 161ILE A 221 | None | 1.02A | 4dz2A-5jcvA:undetectable4dz2B-5jcvA:undetectable | 4dz2A-5jcvA:18.584dz2B-5jcvA:18.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5m99 | ALPHA-AMYLASE (Thermotogapetrophila) |
PF00128(Alpha-amylase) | 5 | ASP B 213VAL B 195ILE B 198TYR B 88ILE B 85 | EDO B 616 ( 2.8A)NoneNoneNoneNone | 1.28A | 4dz2A-5m99B:undetectable4dz2B-5m99B:undetectable | 4dz2A-5m99B:12.674dz2B-5m99B:12.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5msz | THERMOBIA DOMESTICADOMESTICA AA15 (Thermobiadomestica) |
no annotation | 5 | ASP A 84VAL A 72ILE A 190TYR A 75ILE A 81 | None | 1.11A | 4dz2A-5mszA:undetectable4dz2B-5mszA:undetectable | 4dz2A-5mszA:18.584dz2B-5mszA:18.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5o8x | SOLUBLE LYTICTRANSGLYCOSYLASE B (Pseudomonasaeruginosa) |
no annotation | 5 | MET A 292ARG A 233VAL A 267ILE A 272ILE A 222 | None | 0.81A | 4dz2A-5o8xA:undetectable4dz2B-5o8xA:undetectable | 4dz2A-5o8xA:19.474dz2B-5o8xA:19.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5v8t | UBIQUITIN-LIKEPROTEINSMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei;Saccharomycescerevisiae) |
no annotation | 10 | TYR A 33ASP A 44ARG A 49PHE A 53VAL A 62ILE A 63TRP A 66TYR A 89ILE A 98PHE A 106 | 8ZV A 201 (-3.8A)8ZV A 201 (-3.9A)8ZV A 201 (-3.6A)8ZV A 201 (-3.9A)8ZV A 201 (-3.6A)8ZV A 201 (-4.0A)8ZV A 201 (-3.3A)8ZV A 201 (-4.6A)8ZV A 201 ( 4.8A)8ZV A 201 (-4.6A) | 0.63A | 4dz2A-5v8tA:24.34dz2B-5v8tA:24.3 | 4dz2A-5v8tA:21.854dz2B-5v8tA:21.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vf3 | MAJOR CAPSID PROTEIN (Escherichiavirus T4) |
PF07068(Gp23) | 5 | TYR A 424ASP A 110VAL A 307ILE A 310PHE A 375 | None | 1.40A | 4dz2A-5vf3A:undetectable4dz2B-5vf3A:undetectable | 4dz2A-5vf3A:12.904dz2B-5vf3A:12.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x59 | S PROTEIN (Middle Eastrespiratorysyndrome-relatedcoronavirus) |
PF01601(Corona_S2)PF09408(Spike_rec_bind) | 5 | TYR A 469ASP A 444ARG A 401VAL A 458ILE A 480 | None | 1.39A | 4dz2A-5x59A:undetectable4dz2B-5x59A:undetectable | 4dz2A-5x59A:6.774dz2B-5x59A:6.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringae groupgenomosp. 3) |
PF00254(FKBP_C) | 6 | PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.12A | 4dz2A-5xb0A:16.64dz2B-5xb0A:16.6 | 4dz2A-5xb0A:37.504dz2B-5xb0A:37.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringae groupgenomosp. 3) |
PF00254(FKBP_C) | 8 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.67A | 4dz2A-5xb0A:16.64dz2B-5xb0A:16.6 | 4dz2A-5xb0A:37.504dz2B-5xb0A:37.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5z0y | SERINEHYDROXYMETHYLTRANSFERASE (Komagataellaphaffii) |
no annotation | 5 | TYR A 339ASP A 418VAL A 393ILE A 395PHE A 334 | None | 1.28A | 4dz2A-5z0yA:undetectable4dz2B-5z0yA:undetectable | 4dz2A-5z0yA:19.644dz2B-5z0yA:19.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6b4p | PEPTIDYLPROLYLISOMERASE (Naegleriafowleri) |
no annotation | 10 | TYR A 38ASP A 49ARG A 54PHE A 58VAL A 67ILE A 68TRP A 71TYR A 94ILE A 103PHE A 111 | None | 0.74A | 4dz2A-6b4pA:19.94dz2B-6b4pA:19.9 | 4dz2A-6b4pA:49.574dz2B-6b4pA:49.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6bsz | METABOTROPICGLUTAMATE RECEPTOR 8 (Homo sapiens) |
no annotation | 5 | TYR A 344ASP A 84ARG A 355VAL A 402ILE A 406 | None | 1.37A | 4dz2A-6bszA:undetectable4dz2B-6bszA:undetectable | 4dz2A-6bszA:17.704dz2B-6bszA:17.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6du8 | - (-) |
no annotation | 5 | TYR A 366PHE A 362VAL A 109ILE A 108ILE A 453 | None | 1.38A | 4dz2A-6du8A:undetectable4dz2B-6du8A:undetectable | 4dz2A-6du8A:undetectable4dz2B-6du8A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ez4 | RNA POLYMERASEII-ASSOCIATEDPROTEIN 3 (Homo sapiens) |
no annotation | 5 | VAL A 595ILE A 594TYR A 578ILE A 573PHE A 556 | None | 1.40A | 4dz2A-6ez4A:undetectable4dz2B-6ez4A:undetectable | 4dz2A-6ez4A:14.784dz2B-6ez4A:14.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6h20 | - (-) |
no annotation | 5 | ASP A 129ARG A 297VAL A 160ILE A 158ILE A 88 | None | 1.31A | 4dz2A-6h20A:undetectable4dz2B-6h20A:undetectable | 4dz2A-6h20A:undetectable4dz2B-6h20A:undetectable |